Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
- Authors
- Park, Hyun-Sun; Kim, Jongmin; Ahn, Seong Hoon; Ryu, Hong-Yeoul
- Issue Date
- May-2021
- Publisher
- MDPI
- Keywords
- histone deacetylase (HDAC); depression; biomarker; anti-depressant therapy
- Citation
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.22, no.10, pp 1 - 16
- Pages
- 16
- Journal Title
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Volume
- 22
- Number
- 10
- Start Page
- 1
- End Page
- 16
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/146629
- DOI
- 10.3390/ijms22105398
- ISSN
- 1661-6596
1422-0067
- Abstract
- Depression is a highly prevalent, disabling, and often chronic illness that places substantial burdens on patients, families, healthcare systems, and the economy. A substantial minority of patients are unresponsive to current therapies, so there is an urgent need to develop more broadly effective, accessible, and tolerable therapies. Pharmacological regulation of histone acetylation level has been investigated as one potential clinical strategy. Histone acetylation status is considered a potential diagnostic biomarker for depression, while inhibitors of histone deacetylases (HDACs) have garnered interest as novel therapeutics. This review describes recent advances in our knowledge of histone acetylation status in depression and the therapeutic potential of HDAC inhibitors.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 이과대학 > 생명시스템학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.